A new melphalan hemoperfusion filter (GEN 2) was tested in pigs to assess its effectiveness in filtering melphalan during a simulated medical procedure.
The filter showed a high efficiency of 99.0% in removing melphalan and maintained a low pressure gradient of 20.9 mmHg, indicating good blood flow.
Although some blood components like albumin and platelets decreased during the procedure, the changes are considered manageable in a clinical setting.